Skip to main content
Affluent Medical logo

Affluent Medical — Investor Relations & Filings

Ticker · AFME ISIN · FR0013333077 LEI · 969500N30CO4B5N2GN67 PA Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2024-11-14 Major Shareholding Noti…
Country FR France
Listing PA AFME

About Affluent Medical

https://www.affluentmedical.com

Affluent Medical is a clinical-stage medical technology company that develops innovative, minimally invasive implants designed to restore essential physiological functions. The company's activities are concentrated in two primary therapeutic areas: structural heart disease and urology. It specifically addresses severe mitral valve insufficiency and urinary incontinence. The product pipeline, currently in clinical development, features three key devices: Kalios™, an adjustable annuloplasty ring for mitral valve repair; Epygon™, a biomimetic mitral valve for replacement procedures; and Artus™, an electronic artificial urinary sphincter for treating urinary incontinence. Affluent Medical's technologies are engineered to be adjustable and biomimetic, allowing for implantation via minimally invasive surgery and adaptation to both the patient's anatomy and the progression of their pathology.

Recent filings

Filing Released Lang Actions
Franchissement de seuil
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to a declaration of crossing a threshold, specifically related to share ownership thresholds regulated by French commercial law (Article L. 233-7). It details that Truffle Capital crossed a threshold of voting rights in AFFLUENT MEDICAL. This type of filing, reporting changes in significant share ownership or control, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is a formal regulatory disclosure regarding ownership changes, not a general regulatory announcement (RNS) or a report itself.
2024-11-14 French
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.24.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details the 'Nombre d'actions composant le capital social et nombre total de droits de vote' (Number of shares comprising the share capital and total number of voting rights) as of a specific date (31/10/2024). This information is mandated by French regulations (Article L. 233-8 II of the Commercial Code and Article 223-16 of the AMF General Regulation). This type of periodic disclosure regarding share capital and voting rights is a specific regulatory filing requirement, often related to changes in major shareholdings or capital structure, but the core content here is the official count of shares and votes. While it touches upon share capital, it is not a general capital change announcement (SHA) or a major shareholding notification (MRQ) in the sense of crossing a threshold, but rather a mandatory periodic statement of the current structure. Given the options, this specific disclosure about the total number of voting rights and shares, often published monthly or quarterly by listed companies in France, fits best under the general 'Regulatory Filings' (RNS) category as it is a mandatory regulatory disclosure that doesn't perfectly align with the more specific financial report types (10-K, IR, ER) or transaction types (SHA, POS, DIRS). It is a formal regulatory update.
2024-11-07 French
Affluent Medical Announces Participation in Upcoming Scientific Events.
Regulatory Filings Classification · 100% confidence The document is titled "PRESS RELEASE" and announces the company's participation in upcoming scientific conferences (EACTS 2024, ICS 2024, PCR London Valves) during the fourth quarter of 2024. It provides updates on product development (KaliosTM, Epygon, Artus) and includes quotes from the CEO. This format—a formal announcement of future events and business updates, released via press release—does not fit the specific definitions for 10-K, ER, IR, or CT. It is not a formal regulatory filing like a DEF 14A or DVA. Since it is a general corporate announcement detailing business activities and upcoming engagements, it best fits the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS), or potentially a general Investor Presentation (IP) if it were a slide deck, but as a press release detailing activities, RNS is the most appropriate catch-all for non-standard, timely corporate news.
2024-10-08 English
Affluent Medical annonce sa participation à des événements scientifiques à venir.
Regulatory Filings Classification · 100% confidence The document is a press release from Affluent Medical dated October 8, 2024, announcing its participation in several upcoming scientific conferences (EACTS 2024, ICS 2024, Valves PCR London) during Q4 2024. It provides updates on its medical device programs (KALIOSTM, EPYGON, ARTUS) and includes quotes from the CEO. This type of announcement, detailing future participation in industry events and providing general business/product updates outside of mandatory financial reporting periods (like 10-K or IR), is best classified as a general corporate communication. Since it is not a formal financial report, earnings release, or a specific regulatory filing like a Director's Dealing or Capital Change, it falls under the general category for corporate news releases that don't fit elsewhere, which is Regulatory Filings (RNS) as per the provided definitions, acting as a broad announcement category.
2024-10-08 French
Affluent Medical Announces Participation in Upcoming Scientific Events
Regulatory Filings Classification · 100% confidence The document is a press release dated October 8, 2024, announcing the company's participation in several upcoming scientific conferences (EACTS 2024, ICS 2024, PCR London Valves) during Q4 2024. It details the company's progress on its medical devices (KALIOS TM, EPYGON, ARTUS) and includes quotes from the CEO. This type of announcement, focusing on corporate activities, scientific engagement, and product pipeline updates, is characteristic of general corporate news dissemination. Since it is not a formal financial report (like 10-K or IR), an earnings release (ER), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate classification is the general regulatory announcement/news category, which aligns best with 'Regulatory Filings' (RNS) when other specific categories do not fit, as it is disseminated via the EQS News service.
2024-10-08 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.24.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it contains 'Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des Marchés Financiers (AMF)'. It provides a table detailing the 'Nombre d'actions' and 'Nombre total de droits de vote' as of a specific date (30/09/2024). This type of mandatory disclosure regarding share capital and voting rights is a specific regulatory filing requirement in France, often related to major shareholding changes or periodic updates. While it is a regulatory announcement, it is not a general 'RNS' or a report itself (like 10-K or IR). It is a specific disclosure about capital structure and voting rights, which is best categorized under 'Major Shareholding Notification' (MRQ) as it deals with the calculation basis for crossing shareholding thresholds, or potentially 'Share Issue/Capital Change' (SHA). Given the focus on the total number of voting rights and shares, which is a key component of major shareholding disclosures, MRQ is a strong fit, although it is a very specific French regulatory disclosure. Since the document is short and appears to be a press release format announcing this specific regulatory data point, it aligns closely with the nature of mandatory periodic disclosures about ownership structure. However, looking at the provided definitions, there isn't a perfect fit for a 'Voting Rights Disclosure' outside of DVA (which is for voting *results*). Since it details the *basis* for voting rights and share count, and is a mandatory regulatory update, it is a specific type of capital/shareholder information. Given the options, and the fact that it is a formal announcement of share/vote count required by regulators, it is most closely related to capital structure updates or major shareholding notifications. Since it is a formal, periodic disclosure of the share base, and not a transaction (POS) or a general capital change (SHA), and not voting results (DVA), I will classify it as a specific regulatory filing that updates the base for ownership thresholds, which often falls under MRQ or RNS. Given the highly specific nature of the data (voting rights calculation basis), and the lack of a dedicated code, RNS (Regulatory Filings - fallback) is the safest general classification for a specific regulatory data release that doesn't fit the other categories perfectly, although MRQ is tempting due to the threshold context. Re-evaluating: This document is a mandatory disclosure of the total number of shares and voting rights, which is a prerequisite for monitoring shareholding thresholds. This is a common component of disclosures related to significant ownership changes. I will classify it as MRQ (Major Shareholding Notification) as it directly relates to the structure underpinning share ownership reporting, even if it's not a notification of *crossing* a threshold, but the current state of the base count. The document length is short (3363 chars), suggesting it's an announcement of this data rather than a full report, but MRQ is a specific information type, not just an announcement wrapper like RPA/RNS. I will proceed with MRQ as the most relevant content category.
2024-10-07 French

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.